Sentence examples for paclitaxel which has from inspiring English sources

Nab-paclitaxel is a novel Cremophor®-free nanoparticle of albumin-stabilized paclitaxel, which has favorable efficacy and toxicity characteristics relative to other solvent-based taxanes, such as paclitaxel and docetaxel.

The current chemotherapeutic in common clinical use is platinum combined with Paclitaxel, which has enhanced drug toxicity.

As shown in Figure 2 the result also shows that the microtubule of Cellular Component is sensitive to the drug action of Paclitaxel which has been validated from literature [ 24].

For the present study, the second agent selected for combination treatment with irinotecan was paclitaxel, which has been tested as first-line combined treatment for advanced NSCLC (Chang et al, 1996; Greco and Hainsworth, 1997; Belani et al, 1999; Bonomi et al, 2000; Stathopoulos et al, 2004).

Robert A. Holton, a professor of chemistry at Florida State, developed the first total synthesis of the anti-cancer drug paclitaxel, which had previously been obtainable only from the bark of the Pacific yew tree.

There were 3 drugs that had positive connection scores to the cervical cancer signature with a perturbation stability of 1 and a SetS of 5 (diphemanil metilsulfate, riluzole and sulfamethoxazole) along with genistein and paclitaxel which

This has been observed with Toll-like receptor 2 (TLR4), TLR4 and TLR9 agonists, such as BCG and paclitaxel, which have demonstrated significant benefit for the treatment of bladder and breast cancers [ 9- 11].

Taxus chinensis (Pilger) Rehd is widely distributed in China and the northern hemisphere, and the most popular medicinal component isolated from Taxus chinensis is paclitaxel (PTX), which has now become the first-line chemotherapeutic drug for breast cancer and ovarian cancer.

Also, it was gratifying to see that both TTP and OS were significantly higher in the EoP arm when compared to paclitaxel arm, which has not been usual for randomised CT trials involving patients with ABC.

A planned novel trial design allowed the use of patients from CALGB 9342 in the paclitaxel every 3 weeks study arm, which has raised some controversy.

We used paclitaxel that is a microtubule-stabilizing agent, which has previously been shown to induce cell death that is significantly inhibited in Casp2 −/− mouse embryonic fibroblasts.